CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 99 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $56,000 | -79.2% | 30,340 | -6.4% | 0.00% | -95.0% |
| Q4 2019 | $269,000 | +74.7% | 32,403 | +55.5% | 0.08% | +40.4% |
| Q3 2019 | $154,000 | -72.1% | 20,843 | -57.6% | 0.06% | -72.1% |
| Q2 2019 | $551,000 | -51.7% | 49,123 | -35.0% | 0.20% | -35.8% |
| Q4 2018 | $1,141,000 | -7.7% | 75,586 | +13.1% | 0.32% | +19.1% |
| Q3 2018 | $1,236,000 | +149.7% | 66,809 | +208.6% | 0.27% | +159.2% |
| Q2 2018 | $495,000 | -18.3% | 21,650 | +1.6% | 0.10% | -12.0% |
| Q1 2018 | $606,000 | -44.0% | 21,300 | -58.4% | 0.12% | -54.1% |
| Q4 2017 | $1,082,000 | +29.9% | 51,233 | +11.7% | 0.26% | +34.2% |
| Q3 2017 | $833,000 | +54.5% | 45,853 | +31.8% | 0.19% | +25.8% |
| Q2 2017 | $539,000 | – | 34,803 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,803,700 | $25,130,000 | 0.91% |
| Altium Capital Management LP | 663,800 | $2,874,000 | 0.79% |
| Rubric Capital Management LP | 2,406,449 | $10,420,000 | 0.49% |
| RTW INVESTMENTS, LP | 6,029,700 | $26,109,000 | 0.38% |
| Orbimed Advisors | 3,214,509 | $13,919,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 152,345 | $660,000 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 980,085 | $4,244,000 | 0.12% |
| Point72 Asset Management, L.P. | 6,303,025 | $27,292,000 | 0.11% |
| Sender Co & Partners, Inc. | 40,720 | $176,000 | 0.09% |
| Manteio Capital LLC | 15,067 | $65,000 | 0.08% |